Angiogenin-mediated ribosomal RNA transcription as a molecular target for treatment of head and neck squamous cell carcinoma.

Oral Oncology
Lili Chen, Guo-Fu Hu

Abstract

Squamous cell carcinoma of the head and neck (HNSCC) is the eighth most common disease, affecting approximately 640,000 patients worldwide each year. Despite recent advances in surgery, radiotherapy, and chemotherapy, the overall cure for patients with HNSCC has remained at less than 50% for many decades. Patients with recurrent and metastatic disease have a median survival of only 6-10 months. Systemic chemotherapy is the only treatment option for those patients. New treatment options are thus desperately needed to supplement, complement, or replace currently available therapies. New agents that target molecular and cellular pathways of the disease pathogenesis of HNSCC are promising candidates. One class of these new agents is angiogenesis inhibitors that have been proven effective in the treatment of advanced colorectal, breast, and non-small cell lung cancers. Similar to other solid tumors, angiogenesis plays an important role in the pathogenesis of HNSCC. A number of angiogenic factors including vascular endothelial growth factor (VEGF) and angiogenin (ANG) have been shown to be significantly upregulated in HNSCC. Among them, ANG is unique in which it is a ribonuclease that regulates ribosomal RNA (rRNA) transcription. ANG...Continue Reading

References

Aug 1, 1978·Journal of Cellular Physiology·G C Baxter, C P Stanners
Dec 11, 1992·Science·A E KochR M Strieter
Jan 1, 1992·Growth Factors·W RisauC H Heldin
Jul 1, 1992·European Journal of Pediatrics·L Schweigerer, T Fotsis
Mar 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·F Soncin
Mar 1, 1991·The Journal of Clinical Investigation·F BussolinoA Mantovani
Oct 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·D MaglioneM G Persico
Mar 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·G F HuB L Vallee
Oct 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·K A ThomasS Fitzpatrick
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·A B RobertsJ H Kehrl
Jun 17, 1986·Biochemistry·R ShapiroB L Vallee
Oct 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·R MontesanoL Orci
Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M Fràter-SchröderP Böhlen
Nov 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J BadetD Barritault
Apr 1, 1987·Antimicrobial Agents and Chemotherapy·P D WilliamsG H Hottendorf
Sep 1, 1986·Antimicrobial Agents and Chemotherapy·S AuJ Schacht
Jul 1, 1994·The Journal of Experimental Medicine·G MontrucchioG Camussi
May 23, 1995·Proceedings of the National Academy of Sciences of the United States of America·A AlbiniB Ensoli
Jun 15, 1995·Biochemical and Biophysical Research Communications·S JimiH Ishikawa
Jun 1, 1995·Current Opinion in Cell Biology·T Mélèse, Z Xue
Apr 26, 1995·Biochemical and Biophysical Research Communications·D H Kozian, H G Augustin
Jan 17, 1995·Proceedings of the National Academy of Sciences of the United States of America·K A OlsonB L Vallee
Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·G HuB L Vallee
Mar 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·J Moroianu, J F Riordan
Dec 15, 1993·Biochemical and Biophysical Research Communications·G F Hu, J F Riordan
Jan 21, 1993·The New England Journal of Medicine·E E VokesW K Hong
Sep 6, 1996·The Journal of Biological Chemistry·E M ClarkeD L Riggs
Jun 1, 1996·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·S GansaugeH G Beger
Apr 1, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·M S Pepper
Jan 1, 1997·Journal of Cancer Research and Clinical Oncology·V ChopraE V Hannigan
Mar 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·G F HuB L Vallee
Jul 1, 1997·Trends in Biochemical Sciences·F BussolinoG Persico
Jan 1, 1997·Journal of Clinical Gastroenterology·M KaminishiM Tatematsu
May 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·R PiccoliJ W Fett

❮ Previous
Next ❯

Citations

Feb 26, 2013·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Gino MarioniStella Blandamura
Jan 2, 2015·Cancer Chemotherapy and Pharmacology·Yaping LiuYunxia Wu
Aug 16, 2016·BioMed Research International·Masaru Yoshikawa, Yoichi Robertus Fujii
Feb 5, 2016·Biomarker Insights·Kevin W DiebelLynne T Bemis

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Norie YoshiokaGuo-Fu Hu
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Soichiro IbaragiGuo-Fu Hu
Biochemical and Biophysical Research Communications
Zheng-ping XuGuo-Fu Hu
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Yang YuanSheng-dong Huang
© 2021 Meta ULC. All rights reserved